TransCelerate accreditation

TransCelerate Accreditation

ICH GCP training (Good Clinical Practice E6 (R2)) performed by BioResearch, which is dedicated for our employees and external entities, was accredited by TransCelerate Biopharma Inc. and so we joined „GCP Mutual Recognition Program"

TransCelerate organisation aim is to unify GCP trainings for Research Teams and confirms that registered trainings fulfill basic program requirements.

GCP certificates which are issued after finishing the training are accepted by Sponsors and representatives of pharmaceuticals companies all over teh world.

BioResearch training was placed on the list of trainings of Transcelerate Biopharma Inc, which is presented at following link: http://www.transceleratebiopharmainc.com/gcp-training-attestation/training-providers/

What makes the training in BioResearch unique and valuable?

Practical approach supported by many years of experience of the Speakers, who as researchers carried out dozens of projects.

Aim

Preparation of researchers and research centers to perform delegated duties in accordance with GCP, local and international law.

To whom

To experienced and beginning researchers, research team: coordinators, pharmacists, lab technicians, nurses and other involved in the project.

Go back

News

6th anniversary

This week we celebrate our 6th anniversary. Together with our CEO, clinical team and company's friends, we had a pleasure of being at Aga Zaryan's concert and fancy diner.

Read more …

Webinar

We are constantly improving our knowledge to assure the best possible quality of our services.

Read more …

Medical Guide Where to Treat 2022

On 29th of April, a special thematic supplement was published in the Polska The Times and Miasto.pl newspaper - Medical Guide Where to Treat 2022...

Read more …

BRG Support for Ukraine

We are deeply moved and concerned by the events in Ukraine. As a clinical site, focused on the development of medicine and helping other people,...

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲